Skip to content

The effectiveness of trigger point shockwave therapy in rotator cuff tendinopathy: A randomized controlled trial study

The effectiveness of trigger point shockwave therapy in rotator cuff tendinopathy: A randomized controlled trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200924001
Enrollment
60
Registered
2020-09-24
Start date
2020-12-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tendinopathy with myofascial trigger points at shoulder area Extracorporeal shockwave therapy Myofascial trigger point Rotator cuff tendinopathy

Interventions

Extracorporeal Shock Wave Therapy (ESWT) at myofascial trigger points at shoulder area ,Sham Extracorporeal Shock Wave Therapy (ESWT) at myofascial trigger points at shoulder area
Experimental Device,Active Comparator Device
Extracorporeal Shock Wave Therapy (ESWT) at MTrPs,Sham Extracorporeal Shock Wave Therapy (ESWT) at MTrPs

Sponsors

Prince of Songkla University (PSU)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 35-65 years old 2. Presenting with unilateral rotator cuff tendinopathy with myofascial trigger points at shoulder area 3. Able to communicate

Exclusion criteria

Exclusion criteria: 1. Traumatic rotator cuff tendinitis 2. Complete rotator cuff tear 3. Frozen shoulder 4. Inflammatory arthritis such as rheumatoid arthritis 5. Tumor in shoulder area 6. Infection in shoulder area 7. Coagulopathy 8. History of shoulder fracture 9. History of shoulder surgery

Design outcomes

Primary

MeasureTime frame
Functional ability at baseline, after treatment 4, 6 and 12 weeks Disability of the Arm Shoulder and Hand (DASH) score

Secondary

MeasureTime frame
Shoulder pain at baseline, after treatment 4, 6 and 12 weeks Visual analogue scale (VAS),Shoulder range of motion at baseline, after treatment 4, 6 and 12 weeks Range of motion by standard goniometer

Countries

Thailand

Contacts

Public ContactPongphon Chuchuen

Rehabilitation Medicine Division, Prince of Songkla University

pongphon.c@hotmail.com+66869713352

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026